Protocol ITANET - Registry

Summary

This is a prospective observational study with the aim to create an Italian database for the collection of data on diagnostic approach, therapy and follow up of patients affected by GEP-NET (gastro-enteric-pancreatic neuroendocrine tumours). Data for approximately 200 italian patients were already previously collected in the ENETS database (international database). ENETS decided to interrupt the collection of the data for an indefinite period. For this reason, through an amendment (number 1) to the protocol, ITANET (Italian Association Neuro-endocrine Tumors) decided to transfer the italian data into a national database and to go on with the collection/update of the data, in order not to lose important clinical information.

Eligibility

Inclusion Criteria:

* age\> or = 18 years;
* histologically/cytologically proved diagnosis of NET OR diagnosis supported by a PET Gallium 68 positivity and by at least a contrastografic imaging of second level (CT scan or NMR);
* Diagnosis of GEP-NET not antecedent 1 year since the Informed Consent signature;
* Grading G1, G2, G3 according to the classification WHO 2019;
* Tumor origin in digestive apparatus (GEP NETs) or tumor of unknown origin;
* Signed Informed consent.

Exclusion Criteria:

* Known tumor origin different from digestive apparatus (GEP NETs);
* no evidence of histologically/cytologically proved diagnosis of NET OR diagnosis supported by a PET Gallium 68 positivity and by at least a contrastografic imaging of second level (CT scan or NMR);
* Diagnosis of GEP-NET antecedent 1 year since the Informed Consent signature.

Conditions2

Browse More Trials